AstraZeneca has exercised an option to license a cell therapy from Quell Therapeutics, resulting in a $10m milestone payment ...
It highlights the strong commitment and rapid integration of our respective research teams as well as providing important early validation of our novel CAR-Treg cell therapy approach to autoimmune ...
A University professor has found a new way to treat cancer using different cell compounds, like the NR0B2 protein.
Regenerative medicine has the potential to reshape how we treat diseases, offering new hope for patients requiring cell, ...
While the human body’s immune system is generally able to defend against harmful germs, diseases like cancer are trickier to ...
Privately-held UK firm Quell Therapeutics, which positions itself as a pioneer in developing engineered T-regulatory (Treg) ...
The firm is also studying PTG-007 in patients with early-stage type 1 diabetes, but is looking for a partner for the pivotal trial.
Regenerative medicine holds the extraordinary promise that future patients in need of new cells, tissues or organs will no ...
Researchers collaborated on a novel, highly specific strategy to treat type 1 diabetes using a tagged beta cell transplant in ...